ArticleWomen's health (London, England)
Contraceptive use among women with severe mental illness at Gulu Regional Referral Hospital in Northern Uganda.
Article in Women's health (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing sexual and reproductive health and rights in Africa.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSevere mental illness influences uptake of contraceptive services through a number of factors in developing countries including Uganda. The paucity of data on contraceptive use among females with severe mental illness in sub-Saharan Africa including Uganda impairs the provision of guidelines for proper interventions.
objectivesThis study aimed to determine the magnitude and factors associated with contraceptive use among females with severe mental illness attending the mental health outpatient's clinic at Gulu Regional Referral Hospital.
designThis study used a cross-sectional design.
methodsThis study purposely screened 377 women with severe mental illness who attended Gulu hospital between March and June 2023 for contraceptive use using a semi-structured questionnaire with questions specific to the different contraceptive methods used such as condom use, injectable use, and others. Descriptive and inferential analyses were performed to determine prevalence and factors associated with contraceptive use.
resultsOut of a total of 377 participants, 331 of them ever used at least one contraceptive method after being diagnosed with severe mental illness, that is the prevalence of 87.7%. Not attending school (Adjusted Odds ratio (AOR): 0.08; 95% CI: 0.01-0.46; p = 0.005), being treated for bipolar affective disorder (AOR: 0.03; 95% CI: 0.01-0.54; p = 0.017), taking both antipsychotic and mood stabilizer (AOR: 13.84; 95% CI: 2.42-234.25; p = 0.007), ever being pregnant after being diagnosed with severe mental illness (AOR: 19.21; 95% CI: 3.40-108.34; p = 0.001), desire to have children (AOR: 9.91; 95% CI: 2.28-43.12; p = 0.002), and being aware of contraceptive use (AOR: 0.01; 95% CI: 0.01-0.29; p = 0.006) were more likely to use contraception.
conclusionOur results revealed that nearly nine-tenth women with severe mental illness use contraceptives which is associated with not attending school, being treated for bipolar affective disorder, taking both antipsychotic and mood stabilizer, ever being pregnant, desire to have children, and being aware of contraceptive use. The contraceptive facilities should be included directly in the mental health delivery for easy access, hence maximum use by women with severe mental illness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.